| Literature DB >> 35516460 |
Qi Han1, Feifan Meng1, Ming Chen1, Xiangjun Lu1, Deyuan Zhao1, Dongze Wu1, Tingting Wang2, Rujie Qin1.
Abstract
Objective: To evaluate the early clinical effect of percutaneous endoscopic transforaminal lumbar interbody fusion (PE-TLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) surgery in the treatment of middle-aged and elderly patients with single-level lumbar disc herniation accompanied by lumbar instability.Entities:
Keywords: lumbar disc herniation; middle-aged and elderly; minimally invasive surgery; minimally invasive transforaminal lumbar interbody fusion; percutaneous endoscopic transforaminal lumbar interbody fusion
Year: 2022 PMID: 35516460 PMCID: PMC9064176 DOI: 10.2147/JPR.S371635
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 2.832
Patient Basic Information of Group PE-TLIF and Group MIS-TLIF
| Group PE-TLIF | Group MIS-TLIF | P value | |
|---|---|---|---|
| N | 39 | 43 | |
| Gender (male:female) | 18:21 | 23:20 | 0.66 |
| Age (years) | 60.35±8.04 | 60.98±6.62 | 0.94 |
| BMI (kg/m2) | 23.32±2.52 | 22.98±2.23 | 0.52 |
| Levels (%) | 0.57 | ||
| L3-4 | 9(23%) | 10(23%) | |
| L4-5 | 27(69%) | 24(56%) | |
| L5-S1 | 3(8%) | 9(21%) | |
| Duration of symptoms (years) | 2.24±0.92 | 2.00±0.76 | 0.20 |
| Follow-up (months) | 19.49±2.86 | 19.19±2.22 | 0.60 |
Abbreviations: PE-TLIF, percutaneous endoscopic transforaminal lumbar interbody fusion; MIS-TLIF, minimally invasive transforaminal lumbar interbody fusion; BMI, body mass index.
Figure 1A case of PE-TLIF surgery.
Figure 2A case of MIS-TLIF surgery.
Comparison of Serological Markers in Group PE-TLIF and Group MIS-TLIF
| Serological Markers | Group PE-TLIF | Group MIS-TLIF | P value |
|---|---|---|---|
| IL-6(pg/mL) | |||
| Preoperative | 4.37±0.49 | 4.43±0.49 | 0.57 |
| 3 days | 1.13±0.20* | 1.23±0.12* | |
| CRP (mg/L) | |||
| Preoperative | 5.00±0.78 | 4.89±0.67 | 0.31 |
| 3 days | 75.89±15.83* | 102.71±23.75* | |
| CK (IU/L) | |||
| Preoperative | 62.55±9.61 | 60.71±7.05 | 0.32 |
| 3 days | 355.01±45.92* | 463.41±32.74* |
Note: *Compared with preoperative, P < 0.05. Bold values indicate statistical significance. Values are presented as mean ± SD.
Abbreviations: PE-TLIF, percutaneous endoscopic transforaminal lumbar interbody fusion; MIS-TLIF, minimally invasive transforaminal lumbar interbody fusion; IL-6, interleukin‑6; CRP, C-reactive protein; CK, creatine kinase.
Comparison of Clinical Outcomes Between PE-TLIF and MIS-TLIF
| Clinical Data | Group PE-TLIF | Group MIS-TLIF | P value |
|---|---|---|---|
| VAS back pain | |||
| Preoperative | 7.18±0.72 | 7.36±0.75 | 0.27 |
| 1 week | 3.24±0.48* | 3.95±0.72* | |
| 1 month | 2.47±0.44* | 2.83±0.62* | |
| 3 months | 1.76±0.63* | 1.66±0.54* | 0.47 |
| 6 months | 1.37±1.56* | 1.41±1.25* | 0.89 |
| Final follow up | 0.65±0.49* | 0.76±0.46* | 0.29 |
| VAS leg pain | 0.57 | ||
| Preoperative | 7.41±0.67 | 7.62±0.77 | 0.20 |
| 1 week | 2.71±0.53* | 2.65±0.63* | 0.68 |
| 1 month | 2.13±0.30* | 2.23±0.35* | 0.15 |
| 3 months | 1.74±0.56* | 1.58±0.53* | 0.18 |
| 6 months | 1.47±1.53* | 1.31±1.24* | 0.60 |
| Final follow up | 0.76±0.48* | 0.74±0.42* | 0.84 |
| ODI | 0.32 | ||
| Preoperative | 41.03±2.19 | 41.26±1.90 | 0.61 |
| 1 month | 32.44±2.79* | 32.12±2.40* | 0.58 |
| 3 months | 22.72±1.34* | 22.33±1.23* | 0.17 |
| 6 months | 21.38±5.30* | 20.44±3.20* | 0.33 |
| Final follow up | 12.17±1.28* | 13.00±3.44* | 0.17 |
| JOA | 0.69 | ||
| Preoperative | 11.36±1.93 | 11.05±1.99 | 0.47 |
| 1 month | 15.44±0.99* | 15.79±1.08* | 0.13 |
| 3 months | 20.23±1.97* | 20.51±1.18* | 0.43 |
| 6 months | 21.51±3.32* | 22.00±2.75* | 0.47 |
| Final follow up | 26.56±1.02* | 26.90±0.99* | 0.14 |
| Operative time (minutes) | 146.20±18.25 | 127.90±7.76 | |
| Intraoperative blood loss (mL) | 48.87±7.14 | 86.56±8.90 | |
| Postoperative drainage (mL) | 81.23±9.374 | 150.5±15.12 | |
| Length of hospital stay (days) | 4.79±0.89 | 7.79±0.74 | |
| Time to ambulation after surgery (days) | 6.54±1.07 | 15.35±1.98 | |
| Back to work/ normal lifetime (months) | 3.82±0.92 | 4.43±0.95 | |
| Complications (%) | 12.82%(5/39) | 4.65%(2/43) | 0.25 |
| Recurrence (%) | |||
| 3–6 months | 7.69%(3/39) | 4.65%(2/43) | 0.66 |
| CT fusion rates | |||
| 12 months | 89.74%(35/39) | 95.35%(41/43) | 0.41 |
| Modified MacNaba | |||
| 12 months | 23:13:2:1 | 24:15:3:1 | 0.77 |
Notes: *Compared with preoperative, P < 0.001. Bold values indicate statistical significance. Values are presented as mean ± SD. aExcellent: good: fair: poor.
Abbreviations: PE-TLIF, percutaneous endoscopic transforaminal lumbar interbody fusion; MIS-TLIF, minimally invasive transforaminal lumbar interbody fusion; VAS, visual analog scale; ODI, Oswestry disability index; JOA, Japanese Orthopaedic Association; CT, computed tomography.
Figure 3Comparison of (A) VAS back pain, (B) VAS leg pain, (C) ODI scores, and (D) JOA scores between the PE-TLIF and MIS-TLIF groups.